These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33242359)

  • 21. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy.
    Bajaj JS; Saeian K; Verber MD; Hischke D; Hoffmann RG; Franco J; Varma RR; Rao SM
    Am J Gastroenterol; 2007 Apr; 102(4):754-60. PubMed ID: 17222319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
    Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
    Ampuero J; Montoliú C; Simón-Talero M; Aguilera V; Millán R; Márquez C; Jover R; Rico MC; Sendra C; Serra MÁ; Romero-Gómez M
    J Gastroenterol Hepatol; 2018 Mar; 33(3):718-725. PubMed ID: 28768371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of fatigue on driving skills in patients with hepatic encephalopathy.
    Bajaj JS; Hafeezullah M; Zadvornova Y; Martin E; Schubert CM; Gibson DP; Hoffmann RG; Sanyal AJ; Heuman DM; Hammeke TA; Saeian K
    Am J Gastroenterol; 2009 Apr; 104(4):898-905. PubMed ID: 19277025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis.
    Butterworth RF
    Metab Brain Dis; 2020 Jan; 35(1):75-81. PubMed ID: 31338724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial.
    Mousa N; Abdel-Razik A; Zaher A; Hamed M; Shiha G; Effat N; Elbaz S; Elhelaly R; Hafez M; El-Wakeel N; Eldars W
    Therap Adv Gastroenterol; 2016 Sep; 9(5):684-91. PubMed ID: 27582881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal Naming Test - a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy.
    Agarwal A; Taneja S; Chopra M; Duseja A; Dhiman RK
    Clin Exp Hepatol; 2020 Jun; 6(2):116-124. PubMed ID: 32728628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Selenium Deficiency on the Development of Overt Hepatic Encephalopathy in Patients with Chronic Liver Disease.
    Nakahata Y; Hanai T; Miwa T; Maeda T; Imai K; Suetsugu A; Takai K; Shimizu M
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
    J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retrospective analysis of risk factors of liver cirrhosis combined with overt hepatic encephalopathy: a single -center case-control study].
    Fan YN; Ji TT; Liang RY; Yu YY; Xu JH
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):133-136. PubMed ID: 33685081
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatic encephalopathy and fitness to drive.
    Kircheis G; Knoche A; Hilger N; Manhart F; Schnitzler A; Schulze H; Häussinger D
    Gastroenterology; 2009 Nov; 137(5):1706-15.e1-9. PubMed ID: 19686744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Minimal hepatic encephalopathy: a better diagnostic to improve prognostic].
    Ennaifer R; Cheikh M; Hefaiedh R; Romdhane H; Ben Nejma H; Hadj NB
    Presse Med; 2014 May; 43(5):e127-33. PubMed ID: 24703736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotic yogurt for the treatment of minimal hepatic encephalopathy.
    Bajaj JS; Saeian K; Christensen KM; Hafeezullah M; Varma RR; Franco J; Pleuss JA; Krakower G; Hoffmann RG; Binion DG
    Am J Gastroenterol; 2008 Jul; 103(7):1707-15. PubMed ID: 18691193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy.
    Stawicka A; Jaroszewicz J; Zbrzeźniak J; Sołowianowicz N; Woszczenko A; Świderska M; Flisiak R
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32455895
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Butterworth RF; Kircheis G; Hilger N; McPhail MJW
    J Clin Exp Hepatol; 2018 Sep; 8(3):301-313. PubMed ID: 30302048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.
    Allampati S; Duarte-Rojo A; Thacker LR; Patidar KR; White MB; Klair JS; John B; Heuman DM; Wade JB; Flud C; O'Shea R; Gavis EA; Unser AB; Bajaj JS
    Am J Gastroenterol; 2016 Jan; 111(1):78-86. PubMed ID: 26644276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis.
    Miwa T; Hanai T; Nishimura K; Maeda T; Tajirika S; Imai K; Suetsugu A; Takai K; Yamamoto M; Shimizu M
    PLoS One; 2022; 17(11):e0277829. PubMed ID: 36449492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis.
    Labenz C; Nagel M; Toenges G; Kuchen R; Schattenberg JM; Hilscher M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Eur J Intern Med; 2020 Dec; 82():83-89. PubMed ID: 32873457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Umapathy S; Dhiman RK; Grover S; Duseja A; Chawla YK
    Am J Gastroenterol; 2014 Jul; 109(7):1011-9. PubMed ID: 24777152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.